Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Boehringer Ingelheim
Chinese Patent Office
Chubb
QuintilesIMS
Colorcon
Moodys
US Department of Justice

Generated: June 22, 2018

DrugPatentWatch Database Preview

ENALAPRILAT Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for ENALAPRILAT
Pharmacology for ENALAPRILAT
Medical Subject Heading (MeSH) Categories for ENALAPRILAT
Synonyms for ENALAPRILAT
((S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline
(2S)-1-[(2S)-2-[[(1S)-1-CARBOXY-3-PHENYL-PROPYL]AMINO]PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID
(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxopropyl]-2-pyrrolidinecarboxylic acid
(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic Acid (Enalaprilat)
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
(2S)-1-[(2S)-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
420E729
76420-72-9
84680-54-6 (Parent)
A838696
AB00698268_09
AB00698268_10
AB00698268-05
AB00698268-07
AB00698268-08
AC1NUWEA
AK307635
AKOS015840130
AKOS015892570
API0002543
AS-13013
BDBM50367254
BIDD:GT0752
C-20561
C11720
CC-27458
CC-27459
CC-27460
CCG-101042
CHEBI:4786
CHEMBL577
CPD000466359
D0N5HJ
DB09477
E1302
EAL
EINECS 278-459-3
Enalapril acid
Enalapril diacid
Enalapril impurity C
enalaprilat (anhydrous)
Enalaprilat (USP)
Enalaprilat [INN]
enalaprilat [Spanish]
Enalaprilat anhydrous
ENALAPRILAT DIHYDRATE
ENALAPRILAT INHIBITOR
Enalaprilat, analytical standard
Enalaprilate
Enalaprilate [French]
Enalaprilatum
Enalaprilatum [Latin]
Enalaprilic acid
enalprilat hydrate
GTPL6332
HMS2051H16
HMS2089P04
HMS2232B19
HMS3263O13
KB-50526
L-Proline, 1-(N-(1-carboxt-3-phenylpropyl)-L-alanyl)-, (S)-
L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-
L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-
LP01036
LS-187219
LZFZMUMEGBBDTC-QEJZJMRPSA-N
MCULE-3507396113
MFCD00865786
MK 421 diacid
MK 422
MK-422
MK-422 Dihydrate
MLS000759476
MLS001424138
MolPort-005-943-792
N-(1(S)-Carboxy-3-phenylpropyl)-L-alanyl-L-proline
N-[(1S)-1-(Carboxy)-3-phenylpropyl]-L-alanyl]-L-proline Dihydrate
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2)
N-[(s)-1-carboxy-3-phenyl-propyl]-l-alanyl-l-proline
NC00292
NCGC00164593-01
NCGC00261721-01
NSC-760053
NSC760053
Pharmakon1600-01503833
Q508Q118JM
SAM001246684
SBB065733
SC-17001
SCHEMBL37289
SMR000466359
Tox21_501036
UNII-Q508Q118JM
Vasotec I.V.
Vasotec IV Dihydrate
W-104365
ZINC3812851

US Patents and Regulatory Information for ENALAPRILAT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc ENALAPRILAT enalaprilat INJECTABLE;INJECTION 075634-001 Aug 22, 2000 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ENALAPRILAT enalaprilat INJECTABLE;INJECTION 075458-001 Aug 22, 2000 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica ENALAPRILAT enalaprilat INJECTABLE;INJECTION 078687-001 Dec 23, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira ENALAPRILAT enalaprilat INJECTABLE;INJECTION 075456-001 Aug 22, 2000 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
McKinsey
Farmers Insurance
QuintilesIMS
Deloitte
Covington
Chubb
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.